Oramed Pharmaceuticals Inc.
DE ˙ DB ˙ US68403P2039
3,24 € ↓ -0,02 (-0,77%)
2026-06-05
DEL PRIS
SecurityDE:OJU1 / Oramed Pharmaceuticals Inc.
InstitutionPnc Financial Services Group, Inc.
Latest Disclosed Ownership21,200 shares
Latest Disclosed Value $ 72,080
Pnc Financial Services Group, Inc. ownership in OJU1 / Oramed Pharmaceuticals Inc.

On May 8, 2026 - Pnc Financial Services Group, Inc. filed a 13F-HR form disclosing ownership of 21,200 shares of Oramed Pharmaceuticals Inc. (DE:OJU1) valued at $59,890 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 21,200 shares of Oramed Pharmaceuticals Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $68,688 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 21,200 0 0.00 72 20.00 0.0000
2026-02-06 2025-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 21,200 -2,000 -8.62 60 -1.64 0.0000
2025-11-07 2025-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 23,200 0 0.00 61 17.31 0.0000
2025-08-08 2025-06-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 23,200 -3,000 -11.45 52 -7.14 0.0000
2025-05-09 2025-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 26,200 0 0.00 56 -11.11 0.0000
2025-02-07 2024-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 26,200 0 0.00 63 0.00 0.0000
2024-11-08 2024-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 26,200 0 0.00 64 -5.97 0.0000
2024-08-09 2024-06-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 26,200 0 0.00 67 -11.84 0.0000
2024-05-10 2024-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 26,200 0 0.00 77 26.67 0.0001
2024-03-22 2023-12-31 13F/A-1 ORAMED PHARMACEUTICALS COM NEW 68403P203 26,200 -975 -3.59 61 -14.29 0.0000
2024-02-09 2023-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 26,200 -975 61 0.0000
2023-11-13 2023-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 27,175 3,000 12.41 71 -18.60 0.0001
2023-08-11 2023-06-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 24,175 0 0.00 87 65.38 0.0001
2023-05-15 2023-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 24,175 2,000 9.02 53 -80.45 0.0000
2023-02-10 2022-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 22,175 975 4.60 267 94.16 0.0003
2022-11-10 2022-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 21,200 0 0.00 137 41.24 0.0001
2022-08-12 2022-06-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 21,200 0 0.00 97 -46.99 0.0001
2022-05-12 2022-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 21,200 0 0.00 183 -39.60 0.0002
2022-02-11 2021-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 21,200 0 0.00 303 -34.98 0.0003
2021-11-05 2021-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 21,200 0 0.00 466 64.08 0.0004
2021-08-06 2021-06-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 21,200 0 0.00 284 32.09 0.0003
2021-05-07 2021-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 21,200 0 0.00 215 138.89 0.0002
2021-02-12 2020-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 21,200 0 0.00 90 63.64 0.0001
2020-11-06 2020-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 21,200 0 0.00 55 -26.67 0.0001
2020-08-28 2020-06-30 13F/A-1 ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 75 17.19 0.0001
2020-08-07 2020-06-30 13F ORAMED PHARM COM NEW 68403P203 21,200 0 75 15.5729
2020-05-08 2020-03-31 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 64 -41.28 0.0001
2020-02-07 2019-12-31 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 109 60.29 0.0001
2019-11-08 2019-09-30 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 68 -10.53 0.0001
2019-08-09 2019-06-30 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 76 -1.30 0.0001
2019-05-10 2019-03-31 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 77 20.31 0.0001
2019-02-08 2018-12-31 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 64 -37.86 0.0001
2018-11-09 2018-09-30 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 103 -34.81 0.0001
2018-08-10 2018-06-30 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 158 14.49 0.0002
2018-05-11 2018-03-31 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 138 -27.75 0.0001
2018-02-09 2017-12-31 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 191 -9.48 0.0002
2017-11-13 2017-09-30 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 211 27.88 0.0002
2017-08-11 2017-06-30 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 165 26.92 0.0002
2017-05-12 2017-03-31 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 130 0.00 0.0001
2017-02-10 2016-12-31 13F ORAMED PHARM COM NEW 68403P203 21,200 0 0.00 130 -15.58 0.0001
2016-11-04 2016-09-30 13F ORAMED PHARM COM NEW 68403P203 21,200 7,393 53.55 154 33.91 0.0002
2016-08-05 2016-06-30 13F ORAMED PHARM COM NEW 68403P203 13,807 0 0.00 115 25.00 0.0001
2016-05-06 2016-03-31 13F ORAMED PHARM COM NEW 68403P203 13,807 11,089 407.98 92 300.00 0.0001
2016-02-05 2015-12-31 13F ORAMED PHARM COM NEW 68403P203 2,718 0 0.00 23 53.33 0.0000
2015-11-06 2015-09-30 13F ORAMED PHARM COM NEW 68403P203 2,718 0 0.00 15 0.00 0.0000
2015-08-05 2015-06-30 13F ORAMED PHARM COM NEW 68403P203 2,718 2,718 15 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.